Stay updated on Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.

Latest updates to the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedMajor expansion and refresh of trial locations and statuses (notably more sites and some Recruiting statuses) with updated contacts; several old site entries and locations were removed.SummaryDifference6%
- Check21 days agoChange DetectedUpgrade to v3.1.0 with a large addition of contact phone numbers; previous version v3.0.2 is removed.SummaryDifference0.0%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedADEPT-3 now includes both KarXT and KarXT + KarX-EC arms; the KarXT-only entry is removed, and new identifiers, last update date, revision version, and site/contact information are added.SummaryDifference3%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check50 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous locations and contact information for various local institutions across multiple countries, while also removing outdated location entries and related resources.SummaryDifference34%
- Check64 days agoChange DetectedThe page has updated its recruiting status and contact information for clinical research trials, including new personnel and their respective sites.SummaryDifference0.5%
Stay in the know with updates to Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.